Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Journey Medical Corporation DERM

Full chart Compare
Set alert

Price alert · DERM

All alert types
4.65 USD 0.00 (+0.11%)

Nov 4, 2026, 12:15 PM EST

4.61 Day range 4.85
4.31 52-week range 9.56
YTD
-39.75%
1 year
-48.39%

Financial health

Altman Z-Score

0.70 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -16.4×
FY 2016: -3.5×FY 2017: -1.3×FY 2018: -1.8×FY 2019: 43.2×FY 2020: 29.7×FY 2021: -2.1×FY 2022: -1.1×FY 2023: -27.4×FY 2024: -5.4×FY 2025: -16.4×
FY 2016 5y median -5.4× FY 2025
P/S 3.1×
FY 2016: 13.9×FY 2017: 84.9×FY 2018: 9.4×FY 2019: 4.5×FY 2020: 3.6×FY 2021: 1.5×FY 2022: 0.5×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 3.1×
FY 2016 5y median 1.4× FY 2025
P/B 5.9×
FY 2016: 1.3×FY 2017: 2.6×FY 2018: -44.1×FY 2019: 57.5×FY 2020: 15.4×FY 2021: 2.2×FY 2022: 2.0×FY 2023: 5.2×FY 2024: 4.0×FY 2025: 5.9×
FY 2016 5y median 4.0× FY 2025
P/FCF -15.2×
FY 2016: -4.2×FY 2017: -3.7×FY 2018: -1.9×FY 2019: 23.9×FY 2020: 40.3×FY 2021: -7.6×FY 2022: -1.0×FY 2023: 438×FY 2024: -3.3×FY 2025: -15.2×
FY 2016 5y median -3.3× FY 2025
EV/EBITDA -57.2×
FY 2016: -3.1×FY 2017: -1.3×FY 2018: -3.0×FY 2019: 24.3×FY 2020: 17.1×FY 2021: -1.6×FY 2022: -1.1×FY 2023: 49.6×FY 2024: -10.2×FY 2025: -57.2×
FY 2016 5y median -1.6× FY 2025
EV/Sales 3.1×
FY 2016: 12.0×FY 2017: 81.2×FY 2018: 14.4×FY 2019: 4.5×FY 2020: 3.6×FY 2021: 0.8×FY 2022: 0.3×FY 2023: 1.2×FY 2024: 1.5×FY 2025: 3.1×
FY 2016 5y median 1.2× FY 2025
FCF Yield -6.6%
FY 2016: -23.8%FY 2017: -27.1%FY 2018: -53.6%FY 2019: 4.2%FY 2020: 2.5%FY 2021: -13.1%FY 2022: -99.6%FY 2023: 0.2%FY 2024: -30.2%FY 2025: -6.6%
FY 2016 5y median -13.1% FY 2025

Profitability

Gross Margin 59.3%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 97.2%FY 2019: 69.8%FY 2020: 67.2%FY 2021: 49.2%FY 2022: 58.2%FY 2023: 66.3%FY 2024: 62.8%FY 2025: 59.3%
FY 2016 5y median 59.3% FY 2025
Operating Margin -13.2%
FY 2016: -401.3%FY 2017: -6613.7%FY 2018: -505.4%FY 2019: 15.1%FY 2020: 17.6%FY 2021: -55.2%FY 2022: -37.4%FY 2023: -2.6%FY 2024: -24.4%FY 2025: -13.2%
FY 2016 5y median -24.4% FY 2025
Net Margin -18.5%
FY 2016: -394.4%FY 2017: -6678.3%FY 2018: -523.3%FY 2019: 10.4%FY 2020: 11.9%FY 2021: -69.7%FY 2022: -40.2%FY 2023: -4.9%FY 2024: -26.1%FY 2025: -18.5%
FY 2016 5y median -26.1% FY 2025
ROE -35.9%
FY 2016: -36.0%FY 2017: -202.6%FY 2018: 2450.9%FY 2019: 131.7%FY 2020: 51.3%FY 2021: -104.6%FY 2022: -174.5%FY 2023: -18.9%FY 2024: -73.1%FY 2025: -35.9%
FY 2016 5y median -73.1% FY 2025
ROIC -14.3%
FY 2016: -32.3%FY 2017: -65.3%FY 2018: -69.9%FY 2019: 29.2%FY 2020: 20.4%FY 2021: -68.3%FY 2022: -66.5%FY 2023: -5.4%FY 2024: -29.9%FY 2025: -14.3%
FY 2016 5y median -29.9% FY 2025
ROA -12.1%
FY 2016: -28.5%FY 2017: -54.1%FY 2018: -64.3%FY 2019: 10.7%FY 2020: 10.2%FY 2021: -45.2%FY 2022: -28.2%FY 2023: -5.0%FY 2024: -18.3%FY 2025: -12.1%
FY 2016 5y median -18.3% FY 2025

Growth (YoY)

Revenue 10.2%
FY 2016: 209.4%FY 2017: -79.9%FY 2018: 832.4%FY 2019: -17.5%FY 2020: 27.5%FY 2021: 41.8%FY 2022: 16.7%FY 2023: 7.5%FY 2024: -29.1%FY 2025: 10.2%
FY 2016 FY 2025
Operating Income 40.3%
FY 2016: -13.6%FY 2017: -231.4%FY 2018: 28.8%FY 2019: 102.5%FY 2020: 49.3%FY 2021: -544.3%FY 2022: 21.1%FY 2023: 92.5%FY 2024: -559.8%FY 2025: 40.3%
FY 2016 FY 2025
EPS (diluted) 34.7%
FY 2016: 7.8%FY 2017: -177.0%FY 2018: 29.5%FY 2019: 104.2%FY 2020: 45.5%FY 2021: -893.8%FY 2022: 33.5%FY 2023: 87.6%FY 2024: -242.9%FY 2025: 34.7%
FY 2016 FY 2025
Free Cash Flow 48.4%
FY 2016: -53.9%FY 2017: -39.2%FY 2018: -105.0%FY 2019: 103.1%FY 2020: -40.6%FY 2021: -409.8%FY 2022: -175.3%FY 2023: 100.7%FY 2024: -10152.9%FY 2025: 48.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.8×
FY 2016: 8.1×FY 2017: 5.3×FY 2018: 8.7×FY 2019: 1.2×FY 2020: 1.3×FY 2021: 1.6×FY 2022: 1.2×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 1.8×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 1.5×
FY 2016: 8.1×FY 2017: 5.3×FY 2018: 8.5×FY 2019: 1.2×FY 2020: 1.2×FY 2021: 1.4×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 1.5×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.8×
FY 2016: 0.0×FY 2017: 1.9×FY 2018: -34.7×FY 2019: 1.9×FY 2020: 1.0×FY 2021: 0.2×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 1.3×FY 2025: 0.8×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA -0.4×
FY 2016: 0.5×FY 2017: 0.1×FY 2018: -1.0×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 1.2×FY 2022: 0.4×FY 2023: -5.1×FY 2024: -0.6×FY 2025: -0.4×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -2.2×
FY 2016: -58.8×FY 2017: -36.9×FY 2018: -13.7×FY 2019: 20.6×FY 2020: 11.2×FY 2021: -5.0×FY 2022: -13.6×FY 2023: -1.2×FY 2024: -5.1×FY 2025: -2.2×
FY 2016 5y median -5.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31